Publications by authors named "Marriam AlGashami"
Prz Gastroenterol
March 2024
Article Synopsis
- Clostridioides difficile infection (CDI) is a significant healthcare challenge, with serious health risks, and current management practices are guided by organizations like IDSA, SHEA, and ESCMID.
- Recent advancements in CDI treatment include drugs like fidaxomicin, vancomycin, bezlotoxumab, and fecal microbiota transplantation, each with distinct benefits and challenges.
- Emerging therapies, such as SER-109 and Rebyota, signal a shift in CDI treatment strategies, highlighting the importance of microbiome restoration for improved long-term patient safety.
